AbbVie Total Non-Operating Income/Expense 2010-2024 | ABBV

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

AbbVie annual total non-operating income/expense for 2024 was $-5.421B, a 16.69% decline from 2023.
AbbVie annual total non-operating income/expense for 2023 was $-6.507B, a 40.24% increase from 2022.
AbbVie annual total non-operating income/expense for 2022 was $-4.64B, a 5.98% decline from 2021.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

AbbVie annual total non-operating income/expense for 2024 was $-5.421B, a 16.69% decline from 2023.
AbbVie annual total non-operating income/expense for 2023 was $-6.507B, a 40.24% increase from 2022.
AbbVie annual total non-operating income/expense for 2022 was $-4.64B, a 5.98% decline from 2021.